(a) Whenever any individual or group health, sickness or accident insurance policy or subscriber contract or certificate issued by any entity subject to 40 Pa.C.S. Chs. 61 (relating to hospital plan corporations) and 63 (relating to professional health services plan corporations), this act, or the act of July 29, 1977 (P.L. 105, No. 38), known as the “Fraternal Benefit Society Code,”¹ providing hospital or medical/surgical coverage includes within their coverage benefits for cancer chemotherapy and cancer hormone treatments and services which have been approved by the United States Food and Drug Administration for general use in treatment of cancer, the covered individual shall be entitled to benefits for cancer chemotherapy and cancer hormone treatments, whether performed in a physician's office, in an outpatient department of a hospital, in a hospital as a hospital inpatient or in any other medically appropriate treatment setting.

(b) Nothing in this section shall serve to diminish the benefits of any insured or subscriber in effect on the effective date of this act, nor prevent the offering or acceptance of benefits which exceed the minimum benefits required by this section.

(c) This section shall apply to those insurance policies, subscriber contracts or certificates issued or entered into on or after the effective date of this section.